Literature DB >> 29196464

Deconstruction of a Metastatic Tumor Microenvironment Reveals a Common Matrix Response in Human Cancers.

Oliver M T Pearce1, Robin M Delaine-Smith1,2, Eleni Maniati1, Sam Nichols1, Jun Wang1, Steffen Böhm1, Vinothini Rajeeve1, Dayem Ullah1, Probir Chakravarty3, Roanne R Jones1, Anne Montfort1, Tom Dowe1, John Gribben1, J Louise Jones1, Hemant M Kocher1, Jonathan S Serody4, Benjamin G Vincent4, John Connelly5,6, James D Brenton7, Claude Chelala1, Pedro R Cutillas1, Michelle Lockley1, Conrad Bessant8, Martin M Knight2,3, Frances R Balkwill9,3.   

Abstract

We have profiled, for the first time, an evolving human metastatic microenvironment by measuring gene expression, matrisome proteomics, cytokine and chemokine levels, cellularity, extracellular matrix organization, and biomechanical properties, all on the same sample. Using biopsies of high-grade serous ovarian cancer metastases that ranged from minimal to extensive disease, we show how nonmalignant cell densities and cytokine networks evolve with disease progression. Multivariate integration of the different components allowed us to define, for the first time, gene and protein profiles that predict extent of disease and tissue stiffness, while also revealing the complexity and dynamic nature of matrisome remodeling during development of metastases. Although we studied a single metastatic site from one human malignancy, a pattern of expression of 22 matrisome genes distinguished patients with a shorter overall survival in ovarian and 12 other primary solid cancers, suggesting that there may be a common matrix response to human cancer.Significance: Conducting multilevel analysis with data integration on biopsies with a range of disease involvement identifies important features of the evolving tumor microenvironment. The data suggest that despite the large spectrum of genomic alterations, some human malignancies may have a common and potentially targetable matrix response that influences the course of disease. Cancer Discov; 8(3); 304-19. ©2017 AACR.This article is highlighted in the In This Issue feature, p. 253. ©2017 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 29196464      PMCID: PMC5837004          DOI: 10.1158/2159-8290.CD-17-0284

Source DB:  PubMed          Journal:  Cancer Discov        ISSN: 2159-8274            Impact factor:   39.397


  63 in total

1.  ChEA: transcription factor regulation inferred from integrating genome-wide ChIP-X experiments.

Authors:  Alexander Lachmann; Huilei Xu; Jayanth Krishnan; Seth I Berger; Amin R Mazloom; Avi Ma'ayan
Journal:  Bioinformatics       Date:  2010-08-13       Impact factor: 6.937

Review 2.  Emerging cytokine networks in colorectal cancer.

Authors:  Nathan R West; Sarah McCuaig; Fanny Franchini; Fiona Powrie
Journal:  Nat Rev Immunol       Date:  2015-09-11       Impact factor: 53.106

Review 3.  Microenvironmental regulation of tumor progression and metastasis.

Authors:  Daniela F Quail; Johanna A Joyce
Journal:  Nat Med       Date:  2013-11       Impact factor: 53.440

Review 4.  Proteoglycans: from structural compounds to signaling molecules.

Authors:  Liliana Schaefer; Roland M Schaefer
Journal:  Cell Tissue Res       Date:  2009-06-10       Impact factor: 5.249

5.  A COL11A1-correlated pan-cancer gene signature of activated fibroblasts for the prioritization of therapeutic targets.

Authors:  Dongyu Jia; Zhenqiu Liu; Nan Deng; Tuan Zea Tan; Ruby Yun-Ju Huang; Barbie Taylor-Harding; Dong-Joo Cheon; Kate Lawrenson; Wolf R Wiedemeyer; Ann E Walts; Beth Y Karlan; Sandra Orsulic
Journal:  Cancer Lett       Date:  2016-09-05       Impact factor: 8.679

Review 6.  Tissue Force Programs Cell Fate and Tumor Aggression.

Authors:  Jason J Northey; Laralynne Przybyla; Valerie M Weaver
Journal:  Cancer Discov       Date:  2017-10-16       Impact factor: 39.397

7.  Fibronectin 1 mRNA expression correlates with advanced disease in renal cancer.

Authors:  Sandra Waalkes; Faranaz Atschekzei; Mario W Kramer; Jörg Hennenlotter; Gesa Vetter; Jan U Becker; Arnulf Stenzl; Axel S Merseburger; Andres J Schrader; Markus A Kuczyk; Jürgen Serth
Journal:  BMC Cancer       Date:  2010-09-22       Impact factor: 4.430

8.  Cartilage oligomeric matrix protein contributes to the development and metastasis of breast cancer.

Authors:  E Englund; M Bartoschek; B Reitsma; L Jacobsson; A Escudero-Esparza; A Orimo; K Leandersson; C Hagerling; A Aspberg; P Storm; M Okroj; H Mulder; K Jirström; K Pietras; A M Blom
Journal:  Oncogene       Date:  2016-04-11       Impact factor: 9.867

9.  Stromal gene expression predicts clinical outcome in breast cancer.

Authors:  Greg Finak; Nicholas Bertos; Francois Pepin; Svetlana Sadekova; Margarita Souleimanova; Hong Zhao; Haiying Chen; Gulbeyaz Omeroglu; Sarkis Meterissian; Atilla Omeroglu; Michael Hallett; Morag Park
Journal:  Nat Med       Date:  2008-04-27       Impact factor: 53.440

Review 10.  Inflammation and cancer: advances and new agents.

Authors:  Shanthini M Crusz; Frances R Balkwill
Journal:  Nat Rev Clin Oncol       Date:  2015-06-30       Impact factor: 66.675

View more
  98 in total

1.  Ovarian Cells Have Increased Proliferation in Response to Heparin-Binding Epidermal Growth Factor as Collagen Density Increases.

Authors:  Kaitlin C Fogg; Carine M Renner; Hannah Christian; Alyssa Walker; Leilani Marty-Santos; Aisha Khan; Will R Olson; Carl Parent; Andrea O'Shea; Deneen M Wellik; Paul S Weisman; Pamela K Kreeger
Journal:  Tissue Eng Part A       Date:  2020-06-25       Impact factor: 3.845

2.  Migration dynamics of ovarian epithelial cells on micro-fabricated image-based models of normal and malignant stroma.

Authors:  Samuel Alkmin; Rebecca Brodziski; Haleigh Simon; Daniel Hinton; Randall H Goldsmith; Manish Patankar; Paul J Campagnola
Journal:  Acta Biomater       Date:  2019-09-27       Impact factor: 8.947

Review 3.  Designer Self-Assembling Peptide Hydrogels to Engineer 3D Cell Microenvironments for Cell Constructs Formation and Precise Oncology Remodeling in Ovarian Cancer.

Authors:  Zehong Yang; Hongyan Xu; Xiaojun Zhao
Journal:  Adv Sci (Weinh)       Date:  2020-03-20       Impact factor: 16.806

Review 4.  Charting the unexplored extracellular matrix in cancer.

Authors:  Elysse C Filipe; Jessica L Chitty; Thomas R Cox
Journal:  Int J Exp Pathol       Date:  2018-04-19       Impact factor: 1.925

Review 5.  The matrix in cancer.

Authors:  Thomas R Cox
Journal:  Nat Rev Cancer       Date:  2021-02-15       Impact factor: 60.716

Review 6.  Immunotherapy: breaching the barriers for cancer treatment.

Authors:  Victor G Martinez; Danielle Park; Sophie E Acton
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2019-07-01       Impact factor: 6.237

7.  Collagen Remodeling in the Hypoxic Tumor-Mesothelial Niche Promotes Ovarian Cancer Metastasis.

Authors:  Suchitra Natarajan; Kaitlyn M Foreman; Michaela I Soriano; Ninna S Rossen; Hussein Shehade; Daniel R Fregoso; Joshua T Eggold; Venkatesh Krishnan; Oliver Dorigo; Adam J Krieg; Sarah C Heilshorn; Subarna Sinha; Katherine C Fuh; Erinn B Rankin
Journal:  Cancer Res       Date:  2019-03-12       Impact factor: 12.701

8.  Proteomic Profiling of the ECM of Xenograft Breast Cancer Metastases in Different Organs Reveals Distinct Metastatic Niches.

Authors:  Jess D Hebert; Samuel A Myers; Alexandra Naba; Genevieve Abbruzzese; John M Lamar; Steven A Carr; Richard O Hynes
Journal:  Cancer Res       Date:  2020-02-04       Impact factor: 12.701

9.  Collagen-rich omentum is a premetastatic niche for integrin α2-mediated peritoneal metastasis.

Authors:  Yen-Lin Huang; Ching-Yeu Liang; Danilo Ritz; Ricardo Coelho; Dedy Septiadi; Manuela Estermann; Cécile Cumin; Natalie Rimmer; Andreas Schötzau; Mónica Núñez López; André Fedier; Martina Konantz; Tatjana Vlajnic; Diego Calabrese; Claudia Lengerke; Leonor David; Barbara Rothen-Rutishauser; Francis Jacob; Viola Heinzelmann-Schwarz
Journal:  Elife       Date:  2020-10-07       Impact factor: 8.140

Review 10.  Diverse Functions of Macrophages in Different Tumor Microenvironments.

Authors:  Ming Yang; Daniel McKay; Jeffrey W Pollard; Claire E Lewis
Journal:  Cancer Res       Date:  2018-09-11       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.